Cargando…
Expression of Endothelin-A-Receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer
Endothelin-1 (ET-1) and its receptors (ET(A)R and ET(B)R), referred to as the endothelin (ET) axis, are overexpressed in breast carcinomas and appear to influence tumour growth and progression. The objective of this study was to determine the effect of expression of the ET axis in breast carcinomas...
Autores principales: | Wülfing, P, Tio, J, Kersting, C, Sonntag, B, Buerger, H, Wülfing, C, Euler, U, Boecker, W, Tulusan, A H, Kiesel, L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409854/ https://www.ncbi.nlm.nih.gov/pubmed/15226779 http://dx.doi.org/10.1038/sj.bjc.6601889 |
Ejemplares similares
-
Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ
por: Wülfing, P, et al.
Publicado: (2005) -
Egfr Amplification Specific Gene Expression in Phyllodes Tumours of the Breast
por: Agelopoulos, Konstantin, et al.
Publicado: (2007) -
An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ
por: Götte, Martin, et al.
Publicado: (2007) -
Caveolin-1 expression in benign and malignant lesions of the breast
por: Liedtke, Cornelia, et al.
Publicado: (2007) -
Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
por: Radke, I, et al.
Publicado: (2006)